Skip to content

Clinical trials

Myelodysplastic Syndromes trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Country / region: France Clear all

194 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20035
20041
20053
20066
20074
20086
20094
201011
20118
20122
201311
20148
201511
201620
20178
201812
20198
202012
202111
202212
20239
20245
20257
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed84
Terminated33
Recruiting26
Unknown status24
Active, not recruiting15
Withdrawn5
Not yet recruiting3
Enrolling by invitation3
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Groupe Francophone des Myelodysplasies27
Celgene13
Novartis Pharmaceuticals13
European Organisation for Research and Treatment of Cancer - EORTC9
Institut Paoli-Calmettes9
Assistance Publique - Hôpitaux de Paris5
Traws Pharma, Inc.5
Bristol-Myers Squibb4
Institut de Recherches Internationales Servier4
Takeda4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes194
Leukemia, Myeloid, Acute77
Leukemia, Myelomonocytic, Chronic34
Anemia22
Leukemia20
Anemia, Refractory, with Excess of Blasts12
Hematologic Neoplasms11
Myeloproliferative Disorders10
Precursor Cell Lymphoblastic Leukemia-Lymphoma10
Multiple Myeloma9

Trials

Showing 76 to 100 of 194. Each trial links to its page on Pharma Observatory.

94 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.